Abstract
A k nearest neighbor-molecular field analysis (kNN-MFA) of benzimidazole derivatives, a series of hepatitis C virus (HCV) inhibitors, has been performed to determine the factors contributing in the corresponding activities. The energy minimized conformations were obtained by molecular mechanics using VLife QSAR 1.0 package. The developed model was verified by performing leave-one out (LOO) cross-validation, which showed the q2 value of 0.900 and pred_r2 value of 0.783. The model indicates the dominance of the steric field and also points out the regions around the benzamidazole ring where the bulky or less bulky groups can be substituted to increase the activity of the compounds.
Keywords: Anti-HCV agents, benzimidazole derivatives, 3D-QSAR, kNN-MFA
Medicinal Chemistry
Title: A 3D-QSAR Study on a Series of Benzimidazole Derivatives Acting as Hepatitis C Virus Inhibitors: Application of kNN-Molecular Field Analysis
Volume: 6 Issue: 2
Author(s): S.P. Gupta, S. Samanta and Vaishali M. Patil
Affiliation:
Keywords: Anti-HCV agents, benzimidazole derivatives, 3D-QSAR, kNN-MFA
Abstract: A k nearest neighbor-molecular field analysis (kNN-MFA) of benzimidazole derivatives, a series of hepatitis C virus (HCV) inhibitors, has been performed to determine the factors contributing in the corresponding activities. The energy minimized conformations were obtained by molecular mechanics using VLife QSAR 1.0 package. The developed model was verified by performing leave-one out (LOO) cross-validation, which showed the q2 value of 0.900 and pred_r2 value of 0.783. The model indicates the dominance of the steric field and also points out the regions around the benzamidazole ring where the bulky or less bulky groups can be substituted to increase the activity of the compounds.
Export Options
About this article
Cite this article as:
Gupta S.P., Samanta S. and M. Patil Vaishali, A 3D-QSAR Study on a Series of Benzimidazole Derivatives Acting as Hepatitis C Virus Inhibitors: Application of kNN-Molecular Field Analysis, Medicinal Chemistry 2010; 6 (2) . https://dx.doi.org/10.2174/157340610791321460
DOI https://dx.doi.org/10.2174/157340610791321460 |
Print ISSN 1573-4064 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6638 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Malignancy in Common Variable Immune Deficiency: Report of Two Rare Cases of Gastrointestinal Malignancy and a Review of the Literature
Cardiovascular & Hematological Disorders-Drug Targets Advances and Challenges in Drug Design of PPARδ Ligands
Current Drug Targets Conference Report: 14th International Congress on Amino Acids, Peptides and Proteins, Vienna, Austria, August 3-7, 2015
CNS & Neurological Disorders - Drug Targets Current Therapeutic Leads for the Treatment of Melanoma: Targeted Immunotherapy in the Post-genomic Era
Current Molecular Pharmacology Pharmaceutical Treatment of Asthma in Children
Current Drug Targets - Inflammation & Allergy Interleukin-18: Biology and Role in the Immunotherapy of Cancer
Current Medicinal Chemistry Hyperglycemia-induced Oxidative Stress and its Role in Diabetes Mellitus Related Cardiovascular Diseases
Current Pharmaceutical Design Meet Our Editorial Board Member
Current Cancer Drug Targets Oxidant/Antioxidant Imbalance and the Risk of Alzheimer's Disease
Current Alzheimer Research Nanostructures and Substituent Alkyl Chains Effect on Assembly of Organogels Based on Some Glutamic Acid Diethyl Ester Imide Derivatives
Current Nanoscience Perspectives in Medicinal Chemistry
Current Topics in Medicinal Chemistry Drug-Delivery Systems of Green Tea Catechins for Improved Stability and Bioavailability
Current Medicinal Chemistry The Janus Face of Adenosine: Antiarrhythmic and Proarrhythmic Actions
Current Pharmaceutical Design Graphical Abstracts
Clinical Anti-Inflammatory & Anti-Allergy Drugs (Discontinued) The Unique Inhibitory IgG Receptor--FcγRIIb
Protein & Peptide Letters Cholinergic System Dysfunction and Neurodegenerative Diseases: Cause or Effect?
CNS & Neurological Disorders - Drug Targets The New Adipose Tissue and Adipocytokines
Current Diabetes Reviews Gene Delivery for Cancer Therapy
Current Drug Delivery Therapeutic Targeting of CPT-11 Induced Diarrhea: A Case for Prophylaxis
Current Drug Targets Potential Anticancer Properties of Bisphosphonates: Insights From Preclinical Studies
Anti-Cancer Agents in Medicinal Chemistry